Riskpilot← Back to searchSign inGet full accessNordanli AB
ABActiveOrg 5568544968Snickarehusvägen 110-0General medical practice activities · NACE 8621Est. 20111 employees
Revenue 2025
SEK 60K
-47% vs 2024
EBITDA margin
73.1%
-54% vs 2024
Equity ratio
70.8%
Financial strength
Net profit 2025
SEK 36K
-56% vs 2024
| Revenue | SEK 60K | -47% |
| EBITDA | SEK 44K | -54% |
| Net profit | SEK 36K | -56% |
| Total assets | SEK 123K | -21% |
| Equity | SEK 87K | -25% |
| Employees | 1 | — |
Legal name
Nordanli AB
Org number
5568544968
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
30 maj 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva medicinsk konsultation, föreläsnings- och utbildningsverksamhet och därmed förenlig verksamhet. Bolaget skall även bedriva handel med värdepapper samt äga och förvalta, lös och fast egendom.
Address
Snickarehusvägen 110-0
Phone
+46709400477
Email
anne.linnea@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 336 | −0 | 0 | 114 | 60 |
| Staff expenses | — | −0 | — | — | — |
| EBITDA | 90 | −12 | −4 | 96 | 44 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 90 | −12 | −4 | 96 | 44 |
| Net financials | — | — | 0 | 0 | 2 |
| Profit before tax | 90 | −12 | −4 | 96 | 46 |
| Tax | −0 | — | — | −15 | −9 |
| Net profit | 90 | −12 | −4 | 81 | 36 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 271 | 39 | 35 | 155 | 123 |
| Equity | 170 | 38 | 34 | 116 | 87 |
| Long-term debt | 38 | 0 | 0 | — | — |
| Short-term debt | 63 | 0 | — | 40 | 36 |
| Total debt | 101 | 0 | 0 | 40 | 36 |
EBITDA margin
73.1%
This company
15.8%
Market median
+363% vs market
20212025
Equity ratio
70.8%
This company
38.2%
Market median
+85% vs market
20212025
Return on equity
41.6%
This company
18.4%
Market median
+126% vs market
20212025
Net profit margin
60.3%
This company
8.1%
Market median
+644% vs market
20212025
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20212025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
AK Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nordanli AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Kristine Andersson | Chief Executive Officer | 0 companies |
| Anne Linnea Nordström | Board of Directors | 0 companies |
| Dag Georg Juhlberg | Deputy Board Member | 0 companies |
| Martin Fredrik Galeano | Deputy Board Member | 0 companies |